You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial
|
|---|---|
| Published in |
Annals of the Rheumatic Diseases, November 2012
|
| DOI | 10.1136/annrheumdis-2012-202231 |
| Pubmed ID | |
| Authors |
Jean-Yves Reginster, Janusz Badurski, Nicholas Bellamy, William Bensen, Roland Chapurlat, Xavier Chevalier, Claus Christiansen, Harry Genant, Federico Navarro, Evgeny Nasonov, Philip N Sambrook, Timothy D Spector, Cyrus Cooper |
| Abstract |
Strontium ranelate is currently used for osteoporosis. The international, double-blind, randomised, placebo-controlled Strontium ranelate Efficacy in Knee OsteoarthrItis triAl evaluated its effect on radiological progression of knee osteoarthritis. |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 10% |
| Dominican Republic | 1 | 5% |
| Brazil | 1 | 5% |
| Australia | 1 | 5% |
| France | 1 | 5% |
| Netherlands | 1 | 5% |
| India | 1 | 5% |
| Japan | 1 | 5% |
| United Kingdom | 1 | 5% |
| Other | 1 | 5% |
| Unknown | 9 | 45% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 15 | 75% |
| Scientists | 3 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
| Practitioners (doctors, other healthcare professionals) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 226 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Denmark | 2 | <1% |
| Brazil | 1 | <1% |
| India | 1 | <1% |
| Canada | 1 | <1% |
| United Kingdom | 1 | <1% |
| Argentina | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 218 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 34 | 15% |
| Student > Ph. D. Student | 28 | 12% |
| Student > Master | 23 | 10% |
| Professor | 17 | 8% |
| Student > Bachelor | 17 | 8% |
| Other | 53 | 23% |
| Unknown | 54 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 82 | 36% |
| Agricultural and Biological Sciences | 18 | 8% |
| Biochemistry, Genetics and Molecular Biology | 14 | 6% |
| Nursing and Health Professions | 12 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 5% |
| Other | 28 | 12% |
| Unknown | 60 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#1,717,164
of 25,732,188 outputs
Outputs from Annals of the Rheumatic Diseases
#1,029
of 7,813 outputs
Outputs of similar age
#11,179
of 203,041 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#3
of 66 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,813 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,041 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.